IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer

Journal of Medical Microbiology

Volumn 62, Issue PART4, 2013, Pages 591-598

  de la Cruz Herrera, Carlos Felipe ^a   Flores Luna, Lourdes ^a   Gutierrez Xicotencatl, Lourdes ^a   Chihu Amparan, Lilia ^a   Sánchez Aleman, Miguel Angel ^a   Lazcano Ponce, Eduardo ^a   Torres, Javier ^b   Ayala, Guadalupe ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HUMAN; IMMUNOBLOTTING; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NON ATROPHIC GASTRITIS; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875193778     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.050567-0     Document Type: Article

References (43)

1. Anderhuber, W., Steinschifter, W., Schauenstein, E., Gotschuli, A., Habermann, W., Fischer, M., Felsner, P. & Schauenstein, K. (1999). The IgG1/G2 subclass shift-a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck. Br J Cancer 79, 1777-1781.
2. Ayala, G., Torres-Mena, J. & López-Carrillo, L. (2008). Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA. J Med Microbiol 57, 9-14.
3. Backert, S., Tegtmeyer, N. & Selbach, M. (2010). The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15, 163-176.
4. Bergman, M. P., Engering, A., Smits, H. H., van Vliet, S. J., van Bodegraven, A. A., Wirth, H. P., Kapsenberg, M. L., Vandenbroucke-Grauls, C. M., van Kooyk, Y. & Appelmelk, B. J. (2004). Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200, 979-990.
5. Bergman, M., Del Prete, G., van Kooyk, Y. & Appelmelk, B. (2006). Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol 4, 151-159.
6. Brown, L. M. (2000). Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22, 283-297.
7. Camorlinga-Ponce, M., Flores-Luna, L., Lazcano-Ponce, E., Herrero, R., Bernal-Sahagún, F., Abdo-Francis, J. M., Aguirre-García, J., Muñ oz, N. & Torres, J. (2008). Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pyloriassociated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 17, 2498-2504.
8. Chomvarin, C., Ottiwet, O., Hahnvajanawong, C., Intapan, P. M. & Wongwajana, S. (2009). Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Int J Infect Dis 13, 647-654.
9. Correa, P. (1996). Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 5, 477-481.
10. D'Elios, M. M., Manghetti, M., Almerigogna, F., Amedei, A., Costa, F., Burroni, D., Baldari, C. T., Romagnani, S., Telford, J. L. & Del Prete, G. (1997). Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 27, 1751-1755.
11. Du, Y., Agnew, A., Ye, X. P., Robinson, P. A., Forman, D. & Crabtree, J. E. (2006). Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect 8, 52-60.
12. Dzierzanowska-Fangrat, K., Raeiszadeh, M., Dzierzanowska, D., Gladkowska-Dura, M., Celinska-Cedro, D. & Crabtree, J. E. (2003). IgG subclass response to Helicobacter pylori and CagA antigens in children. Clin Exp Immunol 134, 442-446.
13. Eslick, G. D., Lim, L. L., Byles, J. E., Xia, H. H. & Talley, N. J. (1999). Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94, 2373-2379.
14. Haddada, M. H., Escribano, M. J., De Vaux Saint Cyr, C. & Barra, Y. (1984). Variations in the levels of IgG1 and IgG2 subclasses in the sera of normal, immunized and tumor-bearing hamsters. Eur J Cancer Clin Oncol 20, 553-560.
15. Huang, J. Q., Sridhar, S., Chen, Y. & Hunt, R. H. (1998). Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114, 1169-1179.
16. Huang, J. Q., Zheng, G. F., Sumanac, K., Irvine, E. J. & Hunt, R. H. (2003). Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125, 1636-1644.
17. Hussain, R., Kifayet, A. & Chiang, T. J. (1995). Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun 63, 410-415.
18. IARC Working Group (1994). Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61, 1-241.
19. Lagacé, J., Pé loquin, L., Kermani, P. & Montie, T. C. (1995). IgG subclass responses to Pseudomonas aeruginosa a-and b-type flagellins in patients with cystic fibrosis: a prospective study. J Med Microbiol 43, 270-276.
20. Lin, W.-C., Tsai, H.-F., Kuo, S.-H., Wu, M.-S., Lin, C.-W., Hsu, P.-I., Cheng, A.-L. & Hsu, P.-N. (2010). Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 70, 5740-5748.
21. Lottenbach, K. R., Mink, C. M., Barenkamp, S. J., Anderson, E. L., Homan, S. M. & Powers, D. C. (1999). Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect Immun 67, 4935-4938.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
23. Mattsson, A., Tinnert, A., Hamlet, A., Lönroth, H., Bölin, I. & Svennerholm, A. M. (1998). Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pyloriinfected subjects. Clin Diagn Lab Immunol 5, 288-293.
24. Mitchell, H. M., Mascord, K., Hazell, S. L. & Daskalopoulos, G. (2001). Association between the IgG subclass response, inflammation and disease status in Helicobacter pylori infection. Scand J Gastroenterol 36, 149-155.
25. Mitchell, H. M., Ally, R., Wadee, A., Wiseman, M. & Segal, I. (2002). Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand J Gastroenterol 37, 517-522.
26. Mitchell, P., Germain, C., Fiori, P. L., Khamri, W., Foster, G. R., Ghosh, S., Lechler, R. I., Bamford, K. B. & Lombardi, G. (2007). Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 75, 810-819.
27. Monack, D. M., Mueller, A. & Falkow, S. (2004). Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2, 747-765.
28. Nomura, A. M., Lee, J., Stemmermann, G. N., Nomura, R. Y., Perez-Perez, G. I. & Blaser, M. J. (2002). Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 186, 1138-1144.
29. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
30. Peek, R. M., Jr, Miller, G. G., Tham, K. T., Perez-Perez, G. I., Zhao, X., Atherton, J. C. & Blaser, M. J. (1995). Heightened inflammatory response and cytokine expression in vivo to cagA+Helicobacter pylori strains. Lab Invest 73, 760-770.
31. Ren, Z., Pang, G., Clancy, R., Li, L. C., Lee, C. S., Batey, R., Borody, T. & Dunkley, M. (2001). Shift of the gastric T-cell response in gastric carcinoma. J Gastroenterol Hepatol 16, 142-148.
32. Ren, Z., Borody, T., Pang, G., Li, L. C., Dunkley, M. & Clancy, R. (2005). Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma. J Gastroenterol Hepatol 20, 1338-1343.
33. Schauenstein, E., Rabl, H., Steinschifter, W., Hirschmann, C., Estelberger, W. & Schauenstein, K. (1997). Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue. Cancer 79, 1482-1486.
34. Schumann, C., Triantafilou, K., Rasche, F. M., Möricke, A., Vogt, K., Triantafilou, M., Hahn, P., Schneider, E. M. & Lepper, P. M. (2006). Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol 296, 223-228.
35. Suzuki, G., Cullings, H., Fujiwara, S., Hattori, N., Matsuura, S., Hakoda, M., Akahoshi, M., Kodama, K. & Tahara, E. (2007). Lowpositive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev 16, 1224-1228.
36. Wan, Y. Y. & Flavell, R. A. (2009). How diverse-CD4 effector T cells and their functions. J Mol Cell Biol 1, 20-36.
37. Weblacher, M., Leitsberger, A., Tillian, H., Maninger, K., Estelberger, W., Schauenstein, K. & Schauenstein, E. (1993). A decrease in reactive disulfide bonds of serum IgG signals a characteristic change in the IgG subclass patterns of rats bearing experimental tumors. Int Arch Allergy Immunol 102, 340-346.
38. Yamaji, Y., Mitsushima, T., Ikuma, H., Okamoto, M., Yoshida, H., Kawabe, T., Shiratori, Y., Saito, K., Yokouchi, K. & Omata, M. (2002). Weak response of Helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese. Scand J Gastroenterol 37, 148-153.
39. Yamaoka, Y., Kita, M., Kodama, T., Sawai, N., Kashima, K. & Imanishi, J. (1997). Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41, 442-451.
40. Yamaoka, Y., Kodama, T., Kashima, K. & Graham, D. Y. (1999). Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 52, 215-218.
41. Yokota, S., Amano, K., Hayashi, S. & Fujii, N. (1997). Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer. Infect Immun 65, 3509-3512.
42. Yokota, Si., Amano, Ki., Hayashi, S., Kubota, T., Fujii, N. & Yokochi, T. (1998). Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 66, 3006-3011.
43. Zhang, J. & Yu, K. F. (1998). What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280, 1690-1691.